1. Ambrogi, V., Bloch, K., Daturi, S., Griggi, P., Logemann, W., Parenti, M. A., Rabini, T., Tommasini, R.: New oral antidiabetic drugs. Part I. Arzneimittel-Forsch.21, 200?204 (1971)
2. Ambrogi, V., Bloch, K., Cozzi, P., Daturi, S., Logemann, W., Parenti, M.A., Tommasini, R.: New oral antidiabetic drugs. Part II. Arzneimittel-Forsch.21, 204?208 (1971)
3. Ambrogi, V., Bloch, K., Daturi, S., Logemann, W. Parenti, M.A., Tommasini, R.: New oral antidiabetic drugs. Part III. Arzneimittel-Forsch.22, 542?544 (1972)
4. Ambrogi, V., Bloch, K., Daturi, S., Griggi, P., Logemann, W., Mandelli, V., Parenti, M.A., Rabini, T., Usardi, M.M., Tommasini, R.: Pharmacological study on a new oral antidiabetic: N-{4-[?-(5-methyl-pyrazine-2-carboxamido)-ethyl]-benzenesulphonyl}-N?-cyclohexyl-urea or K 4024. Arzneimittel-Forsch.21, 208?215 (1971)
5. Fuccella, L.M., Tamassia, V., Valzelli, G.: Metabolism and kinetics of the hypoglycaemic agent glipizide in man. Comparison with glibenclamide. Clin. Pharm. and New Drugs. (In press)